A Study of Syngenon (BSG-001) for Inhalation in Subjects With Malignant Pleural Effusion and/or Malignant Ascites

Clinical trial NCT03736122 · UNKNOWN

Trial details

NCT number: NCT03736122
Sponsor: BioSyngen Pte Ltd
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Malignant Pleural Effusion Malignant Ascites

Start date: 2019-01-01
Primary completion: 2022-01-01
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.